Stephen Maxted Ansell, MD, PhD

  • 22276 Citations
  • 80 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphoma

Khurana, A., Armand, P. & Ansell, S. M., Jan 1 2020, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalReview article

The immune landscape and response to immune checkpoint blockade therapy in lymphoma

Kline, J., Godfrey, J. & Ansell, S. M., Feb 20 2020, In : Blood. 135, 8, p. 523-533 11 p.

Research output: Contribution to journalArticle

Open Access

Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

LaCasce, A. S., Bociek, R. G., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jan 1 2020, (Accepted/In press) In : British journal of haematology.

Research output: Contribution to journalLetter

Open Access
2019

Activation-induced T-cell exhaustion: too much of a good thing?

Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalComment/debate

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access

An RNA aptamer-based biomarker platform demonstrates high soluble cd25 occupancy by il2 in the serum of follicular lymphoma patients

Veeramani, S., Blackwell, S. E., Thiel, W. H., Yang, Z. Z., Ansell, S. M., Giangrande, P. H. & Weiner, G. J., Jan 1 2019, In : Cancer Immunology Research. 7, 9, p. 1511-1522 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Association between facility volume and mortality of patients with classic Hodgkin lymphoma

Goyal, G., Tella, S. H., Funni, S., Kommalapati, A., Inselman, J. W., Shah, N. D., Go, R. S. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era

Taparra, K., Liu, H., Polley, M. Y., Ristow, K., Habermann, T. M. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Ramchandren, R., Advani, R. H., Ansell, S. M., Bartlett, N. L., Chen, R., Connors, J. M., Feldman, T., Forero-Torres, A., Friedberg, J. W., Gopal, A. K., Gordon, L. I., Kuruvilla, J., Savage, K. J., Younes, A., Engley, G., Manley, T. J., Fenton, K. & Straus, D. J., Jan 1 2019, In : Clinical Cancer Research. 25, 6, p. 1718-1726 9 p.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

14 Scopus citations

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Ellin, F., Maurer, M. J., Srour, L., Farooq, U., Jerkeman, M., Connors, J. M., Smedby, K. E., Bennani, N., Ansell, S. M., Slack, G. W., Cerhan, J. R., Relander, T., Feldman, A. L. & Savage, K. J., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalLetter

Open Access

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

Din, L., Sheikh, M., Kosaraju, N., Smedby, K. E., Bernatsky, S., Berndt, S. I., Skibola, C. F., Nieters, A., Wang, S., McKay, J. D., Cocco, P., Maynadié, M., Foretová, L., Staines, A., Mack, T. M., de Sanjosé, S., Vyse, T. J., Padyukov, L., Monnereau, A., Arslan, A. A. & 72 others, Moore, A., Brooks-Wilson, A. R., Novak, A. J., Glimelius, B., Birmann, B. M., Link, B. K., Stewart, C., Vajdic, C. M., Haioun, C., Magnani, C., Conti, D. V., Cox, D. G., Casabonne, D., Albanes, D., Kane, E., Roman, E., Muzi, G., Salles, G., Giles, G. G., Adami, H. O., Ghesquières, H., De Vivo, I., Clavel, J., Cerhan, J. R., Spinelli, J. J., Hofmann, J., Vijai, J., Curtin, K., Costenbader, K. H., Onel, K., Offit, K., Teras, L. R., Morton, L., Conde, L., Miligi, L., Melbye, M., Ennas, M. G., Liebow, M., Purdue, M. P., Glenn, M., Southey, M. C., Din, M., Rothman, N., Camp, N. J., Wong Doo, N., Becker, N., Pradhan, N., Bracci, P. M., Boffetta, P., Vineis, P., Brennan, P., Kraft, P., Lan, Q., Severson, R. K., Vermeulen, R. C. H., Milne, R. L., Kaaks, R., Travis, R. C., Weinstein, S. J., Chanock, S. J., Ansell, S. M., Slager, S. L., Zheng, T., Zhang, Y., Benavente, Y., Taub, Z., Madireddy, L., Gourraud, P. A., Oksenberg, J. R., Cozen, W., Hjalgrim, H. & Khankhanian, P., Oct 1 2019, In : Genetic epidemiology. 43, 7, p. 844-863 20 p.

Research output: Contribution to journalArticle

3 Scopus citations

Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study

Castillo, J. J., Itchaki, G., Paludo, J., Varettoni, M., Buske, C., Eyre, T. A., Chavez, J. C., Shain, K. H., Issa, S., Palomba, M. L., Pasvolsky, O., Simpson, D., Talaulikar, D., Tam, C. S., Tedeschi, A., Ansell, S. M., Nayak, L. & Treon, S. P., Jan 24 2019, In : Blood. 133, 4, p. 299-305 7 p.

Research output: Contribution to journalArticle

8 Scopus citations
2 Scopus citations

IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features

Sidana, S., Larson, D. P., Greipp, P. T., He, R., McPhail, E. D., Dispenzieri, A., Murray, D. L., Dasari, S., Ansell, S. M., Muchtar, E., Gonsalves, W. I., Kourelis, T. V., Ramirez-Alvarado, M., Kapoor, P., Rajkumar, S. V., Lacy, M. Q., Buadi, F. K., Leung, N., Kyle, R. A., Kumar, S. K. & 2 others, King, R. L. & Gertz, M. A., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Immunotherapy in Hodgkin Lymphoma: The Road Ahead

Ansell, S. M., May 1 2019, In : Trends in Immunology. 40, 5, p. 380-386 7 p.

Research output: Contribution to journalReview article

Immunotransplant: Preventing unintended consequences

Ansell, S. M., Nov 2019, In : Cancer discovery. 9, 11, p. 1487-1489 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Wang, Y., Link, B. K., Witzig, T. E., Maurer, M. J., Allmer, C., King, R. L., Feldman, A. L., Habermann, T. M., Ansell, S. M., Slager, S. L., Cerhan, J. R. & Nowakowski, G. S., Oct 17 2019, In : Blood. 134, 16, p. 1289-1297 9 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma

Wang, Y., Maurer, M. J., Larson, M. C., Allmer, C., Feldman, A. L., Bennani, N., Thompson, C. A., Porrata, L. F., Habermann, T. M., Witzig, T. E., Ansell, S. M., Slager, S. L., Nowakowski, G. S. & Cerhan, J. R., Sep 1 2019, In : British journal of haematology. 186, 6, p. 820-828 9 p.

Research output: Contribution to journalArticle

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

4 Scopus citations

Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 + T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma

Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Price-Troska, T., Jalali, S., Wu, H., Luchtel, R., Polley, M-Y., Novak, A. J. & Ansell, S. M., Feb 19 2019, In : Cell reports. 26, 8, p. 2178-2193.e3

Research output: Contribution to journalArticle

Open Access
8 Scopus citations

Nivolumab for newly diagnosed advanced-stage classic Hodgkin lymphoma: Safety and efficacy in the phase II CheckMate 205 study

Ramchandren, R., Domingo-Domènech, E., Rueda, A., Trněný, M., Feldman, T. A., Lee, H. J., Provencio, M., Sillaber, C., Cohen, J. B., Savage, K. J., Willenbacher, W., Ligon, A. H., Ouyang, J., Redd, R., Rodig, S. J., Shipp, M. A., Sacchi, M., Sumbul, A., Armand, P. & Ansell, S. M., Aug 10 2019, In : Journal of Clinical Oncology. 37, 23, p. 1997-2007 11 p.

Research output: Contribution to journalArticle

20 Scopus citations

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

Ansell, S. M., Minnema, M. C., Johnson, P., Timmerman, J. M., Armand, P., Shipp, M. A., Rodig, S. J., Ligon, A. H., Roemer, M. G. M., Reddy, N., Cohen, J. B., Assouline, S., Poon, M., Sharma, M., Kato, K., Samakoglu, S., Sumbul, A. & Grigg, A., Feb 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 6, p. 481-489 9 p.

Research output: Contribution to journalArticle

28 Scopus citations

Pembrolizumab: Living up to expectations

Ansell, S. M., Oct 3 2019, In : Blood. 134, 14, p. 1114-1115 2 p.

Research output: Contribution to journalComment/debate

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Prognostic significance of PD-L1 and TLR5 expression in peripheral T-cell lymphomas

Zanwar, S. & Ansell, S. M., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalComment/debate

Progression risk stratification of asymptomatic Waldenström macroglobulinemia

Bustoros, M., Sklavenitis-Pistofidis, R., Kapoor, P., Liu, C. J., Kastritis, E., Zanwar, S., Fell, G., Abeykoon, J. P., Hornburg, K., Neuse, C. J., Marinac, C. R., Liu, D., Soiffer, J., Gavriatopoulou, M., Boehner, C., Cappuccio, J. M., Dumke, H., Reyes, K., Soiffer, R. J., Kyle, R. A. & 6 others, Treon, S. P., Castillo, J. J., Dimopoulos, M. A., Ansell, S. M., Trippa, L. & Ghobrial, I. M., Jan 1 2019, In : Journal of Clinical Oncology. 37, 16, p. 1403-1411 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma

Luchtel, R. A., Zimmermann, M. T., Hu, G., Dasari, S., Jiang, M., Oishi, N., Jacobs, H. K., Zeng, Y., Hundal, T., Rech, K. L., Ketterling, R. P., Lee, J. H., Eckloff, B. W., Yan, H., Gaonkar, K. S., Tian, S., Ye, Z., Kadin, M. E., Sidhu, J., Jiang, L. & 11 others, Voss, J., Link, B. K., Syrbu, S. I., Facchetti, F., Bennani, N. N., Slager, S. L., Ordog, T., Kocher, J. P., Cerhan, J. R., Ansell, S. M. & Feldman, A. L., Jun 27 2019, In : Blood. 133, 26, p. 2776-2789 14 p.

Research output: Contribution to journalArticle

4 Scopus citations

Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

Jalali, S., Price-Troska, T., Bothun, C., Villasboas Bisneto, J. J. C. ., Kim, H. J., Yang, Z. Z., Novak, A. J., Dong, H. M. & Ansell, S. M., Mar 1 2019, In : Blood cancer journal. 9, 3, 22.

Research output: Contribution to journalArticle

4 Scopus citations

Sintilimab: another effective immune checkpoint inhibitor in classical Hodgkin lymphoma

Ansell, S. M., Jan 1 2019, In : The Lancet Haematology. 6, 1, p. e2-e3

Research output: Contribution to journalComment/debate

SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma

Chen, Y. P., Kim, H. J., Wu, H., Price-Troska, T., Villasboas, J. C., Jalali, S., Feldman, A. L., Novak, A. J., Yang, Z. Z. & Ansell, S. M., Oct 1 2019, In : Blood cancer journal. 9, 10, 84.

Research output: Contribution to journalArticle

Open Access

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Wu, X., Stenson, M., Abeykoon, J., Nowakowski, K., Zhang, L., Lawson, J., Wellik, L., Li, Y., Krull, J., Wenzl, K., Novak, A. J., Ansell, S. M., Bishop, G. A., Billadeau, D. D., Peng, K. W., Giles, F., Schmitt, D. M. & Witzig, T. E., Jul 25 2019, In : Blood. 134, 4, p. 363-373 11 p.

Research output: Contribution to journalArticle

7 Scopus citations

The highs and lows of immune-checkpoint blockade in lymphoma

Ansell, S. M., May 1 2019, In : Cancer Immunology Research. 7, 5, p. 696-700 5 p.

Research output: Contribution to journalArticle

2 Scopus citations

The potential role of glycogen metabolism in diffuse large B-cell lymphoma

Jalali, S. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalReview article

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

45 Scopus citations

Tumor microenvironment in T-Cell lymphomas

Bennani, N. & Ansell, S. M., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 69-82 14 p. (Cancer Treatment and Research; vol. 176).

Research output: Chapter in Book/Report/Conference proceedingChapter

Two types of amyloidosis presenting in a single patient: a case series

Sidiqi, M. H., McPhail, E., Theis, J. D., Dasari, S., Vrana, J. A., Drosou, M. E., Leung, N., Hayman, S., Rajkumar, S. V., Warsame, R., Ansell, S. M., Gertz, M., Grogan, M. & Dispenzieri, A., Mar 1 2019, In : Blood cancer journal. 9, 3, 30.

Research output: Contribution to journalArticle

3 Scopus citations

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Jain, T., Bar, M., Kansagra, A. J., Chong, E. A., Hashmi, S. K., Neelapu, S. S., Byrne, M., Jacoby, E., Lazaryan, A., Jacobson, C. A., Ansell, S. M., Awan, F. T., Burns, L., Bachanova, V., Bollard, C. M., Carpenter, P. A., DiPersio, J. F., Hamadani, M., Heslop, H. E., Hill, J. A. & 13 others, Komanduri, K. V., Kovitz, C. A., Lazarus, H. M., Serrette, J. M., Mohty, M., Miklos, D., Nagler, A., Pavletic, S. Z., Savani, B. N., Schuster, S. J., Kharfan-Dabaja, M. A., Perales, M. A. & Lin, Y., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalReview article

3 Scopus citations
2018

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, M. L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

4 Scopus citations

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Huet, S., Tesson, B., Jais, J. P., Feldman, A. L., Magnano, L., Thomas, E., Traverse-Glehen, A., Albaud, B., Carrère, M., Xerri, L., Ansell, S. M., Baseggio, L., Reyes, C., Tarte, K., Boyault, S., Haioun, C., Link, B. K., Feugier, P., Lopez-Guillermo, A., Tilly, H. & 10 others, Brice, P., Hayette, S., Jardin, F., Offner, F., Sujobert, P., Gentien, D., Viari, A., Campo, E., Cerhan, J. R. & Salles, G., Apr 1 2018, In : The Lancet Oncology. 19, 4, p. 549-561 13 p.

Research output: Contribution to journalArticle

43 Scopus citations

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

Bachy, E., Maurer, M. J., Habermann, T. M., Gelas-Dore, B., Maucort-Boulch, D., Estell, J. A., Van den Neste, E., Bouabdallah, R., Gyan, E., Feldman, A. L., Bargay, J., Delmer, A., Slager, S. L., da Silva, M. G., Fitoussi, O., Belada, D., Maisonneuve, H., Intragumtornchai, T., Ansell, S. M., Lamy, T. & 5 others, Dartigues, P., Link, B. K., Seymour, J. F., Cerhan, J. R. & Salles, G., Jul 5 2018, In : Blood. 132, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

23 Scopus citations

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts

Ghesquières, H., Larrabee, B. R., Casasnovas, O., Maurer, M. J., McKay, J. D., Ansell, S. M., Montgomery, D., Asmann, Y., Farrell, K., Verney, A., Slager, S. L., Allmer, C., Perrot, A., Delarue, R., Habermann, T. M., Dupuis, J., Link, B. K., Canioni, D., Dogan, A., Cozen, W. & 3 others, Jarrett, R. F., Cerhan, J. R. & Salles, G., Jan 1 2018, In : British Journal of Haematology. 180, 2, p. 286-290 5 p.

Research output: Contribution to journalLetter

3 Scopus citations

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

13 Scopus citations

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

LaCasce, A. S., Gregory Bociek, R., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jul 5 2018, In : Blood. 132, 1, p. 40-48 9 p.

Research output: Contribution to journalArticle

39 Scopus citations

Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

Connors, J. M., Jurczak, W., Straus, D. J., Ansell, S. M., Kim, W. S., Gallamini, A., Younes, A., Alekseev, S., Illés, A., Picardi, M., Lech-Maranda, E., Oki, Y., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Chen, R., Ramchandren, R., Zinzani, P. L. & 9 others, Cunningham, D., Rosta, A., Josephson, N. C., Song, E., Sachs, J., Liu, R., Jolin, H. A., Huebner, D. & Radford, J., Jan 25 2018, In : New England Journal of Medicine. 378, 4, p. 331-344 14 p.

Research output: Contribution to journalArticle

165 Scopus citations
22 Scopus citations